{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:45:39Z","timestamp":1783647939305,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1186\/s12918-019-0693-z","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T11:02:37Z","timestamp":1554462157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Identification of H\u00fcrthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms"],"prefix":"10.1186","volume":"13","author":[{"given":"Yangyang","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yang","family":"Duh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Kloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Babiarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mack","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Thomas","family":"Traweek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Fedorowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Sean","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia C.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"issue":"8","key":"693_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2362.2009.02162.x","volume":"39","author":"S Guth","year":"2009","unstructured":"Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Investig. 2009;39(8):699\u2013706.","journal-title":"Eur J Clin Investig"},{"issue":"8","key":"693_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJM199302253280807","volume":"328","author":"EL Mazzaferri","year":"1993","unstructured":"Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328(8):553\u20139.","journal-title":"N Engl J Med"},{"issue":"17","key":"693_CR3","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMcp031436","volume":"351","author":"L Hegedus","year":"2004","unstructured":"Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351(17):1764\u201371.","journal-title":"N Engl J Med"},{"issue":"1","key":"693_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"key":"693_CR5","unstructured":"Thyroid Carcinoma. In: NCCN Clinical Practice Guidelines in Oncology. Version 1; 2018. \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thyroid.pdf\n                    \n                  . Accessed 2 Aug 2018."},{"issue":"5","key":"693_CR6","first-page":"622","volume":"22","author":"H Gharib","year":"2016","unstructured":"Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and Management of Thyroid Nodules - 2016 update. Endocr Pract. 2016;22(5):622\u201339.","journal-title":"Endocr Pract"},{"key":"693_CR7","unstructured":"Ross DS. Diagnostic approach to and treatment of thyroid nodules. In: Cooper DS, Mulder JE, editors. UpToDate 2018. \n                    https:\/\/www.uptodate.com\n                    \n                  . Accessed 3 Aug 2018."},{"issue":"6","key":"693_CR8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.surg.2013.07.006","volume":"154","author":"JA Sosa","year":"2013","unstructured":"Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154(6):1420\u20137.","journal-title":"Surgery"},{"key":"693_CR9","volume-title":"Increases in thyroid nodule fine needle aspirations, surgeries, and diagnoses of thyroid cancer in the United States","author":"JA Sosa","year":"2013","unstructured":"Sosa JA, Hanna HW, Lanman RB, Robinson KA, Ladenson PW. Increases in thyroid nodule fine needle aspirations, surgeries, and diagnoses of thyroid cancer in the United States. Chicago: American Association of Endocrine Surgeons Annual Scientific Meeting (Abstract); 2013."},{"key":"693_CR10","unstructured":"Cancer Stat Facts: Thyroid Cancer. 2018. \n                    https:\/\/seer.cancer.gov\/statfacts\/html\/thyro.html\n                    \n                  . Accessed 3 Aug 2018."},{"issue":"11","key":"693_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","volume":"27","author":"ES Cibas","year":"2017","unstructured":"Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341\u20136.","journal-title":"Thyroid"},{"issue":"7","key":"693_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/cncy.21703","volume":"124","author":"DN Poller","year":"2016","unstructured":"Poller DN, Baloch ZW, Fadda G, Johnson SJ, Bongiovanni M, Pontecorvi A, et al. Thyroid FNA: new classifications and new interpretations. Cancer Cytopathol. 2016;124(7):457\u201366.","journal-title":"Cancer Cytopathol."},{"issue":"11","key":"693_CR13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167\u2013214.","journal-title":"Thyroid"},{"issue":"10","key":"693_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.5858\/arpa.2015-0154-SA","volume":"140","author":"EA Krauss","year":"2016","unstructured":"Krauss EA, Mahon M, Fede JM, Zhang L. Application of the Bethesda classification for thyroid fine-needle aspiration: institutional experience and meta-analysis. Arch Pathol Lab Med. 2016;140(10):1121\u201331.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"693_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa1203208","volume":"367","author":"EK Alexander","year":"2012","unstructured":"Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705\u201315.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"693_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4274\/2017.26.suppl.05","volume":"26","author":"RT Kloos","year":"2017","unstructured":"Kloos RT. Molecular profiling of thyroid nodules: current role for the Afirma gene expression classifier on clinical decision making. Mol Imaging Radionucl Ther. 2017;26(Suppl 1):36\u201349.","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"3","key":"693_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cyt.12093","volume":"25","author":"A Yazgan","year":"2014","unstructured":"Yazgan A, Balci S, Dincer N, Kiyak G, Tuzun D, Ersoy R, et al. Hurthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology. Cytopathology. 2014;25(3):185\u20139.","journal-title":"Cytopathology"},{"issue":"6","key":"693_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000333232","volume":"55","author":"MT Olson","year":"2011","unstructured":"Olson MT, Clark DP, Erozan YS, Ali SZ. Spectrum of risk of malignancy in subcategories of \u2018atypia of undetermined significance\u2019. Acta Cytol. 2011;55(6):518\u201325.","journal-title":"Acta Cytol"},{"issue":"4","key":"693_CR19","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/ERC-11-0354","volume":"19","author":"V Maximo","year":"2012","unstructured":"Maximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simoes M. The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr Relat Cancer. 2012;19(4):R131\u201347.","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"693_CR20","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1634\/theoncologist.2010-0253","volume":"16","author":"J Cannon","year":"2011","unstructured":"Cannon J. The significance of hurthle cells in thyroid disease. Oncologist. 2011;16(10):1380\u20137.","journal-title":"Oncologist"},{"issue":"5","key":"693_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000441939","volume":"59","author":"CJ VandenBussche","year":"2015","unstructured":"VandenBussche CJ, Adams C, Ali SZ, Olson MT. Cytotechnologist performance for screening Hurthle cell atypia in indeterminate thyroid fine-needle aspirates. Acta Cytol. 2015;59(5):377\u201383.","journal-title":"Acta Cytol"},{"issue":"6","key":"693_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/cyt.12455","volume":"28","author":"P Straccia","year":"2017","unstructured":"Straccia P, Santoro A, Rossi ED, Brunelli C, Mosseri C, Musarra T, et al. Incidence, malignancy rates of diagnoses and cyto-histological correlations in the new Italian reporting system for thyroid cytology: an institutional experience. Cytopathology. 2017;28(6):503\u20138.","journal-title":"Cytopathology"},{"issue":"12","key":"693_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cncy.21605","volume":"123","author":"P Straccia","year":"2015","unstructured":"Straccia P, Rossi ED, Bizzarro T, Brunelli C, Cianfrini F, Damiani D, et al. A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol. 2015;123(12):713\u201322.","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"693_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","volume":"34","author":"I Ganly","year":"2018","unstructured":"Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, et al. Integrated genomic analysis of Hurthle cell Cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell. 2018;34(2):256\u201370 e5.","journal-title":"Cancer Cell"},{"issue":"2","key":"693_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","volume":"34","author":"RK Gopal","year":"2018","unstructured":"Gopal RK, Kubler K, Calvo SE, Polak P, Livitz D, Rosebrock D, et al. Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in Hurthle cell Carcinoma. Cancer Cell. 2018;34(2):242\u201355 e5.","journal-title":"Cancer Cell"},{"issue":"5","key":"693_CR26","doi-asserted-by":"publisher","first-page":"E962","DOI":"10.1210\/jc.2012-3539","volume":"98","author":"I Ganly","year":"2013","unstructured":"Ganly I, Ricarte Filho J, Eng S, Ghossein R, Morris LG, Liang Y, et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013;98(5):E962\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"693_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.humpath.2017.09.004","volume":"69","author":"L Conti","year":"2017","unstructured":"Conti L, Vatrano S, Bertero L, Masu L, Pacchioni D, Daniele L, et al. Mitochondrial DNA \u201ccommon deletion\u201d in post-fine needle aspiration infarcted oncocytic thyroid tumors. Hum Pathol. 2017;69:23\u201330.","journal-title":"Hum Pathol"},{"issue":"12","key":"693_CR28","doi-asserted-by":"publisher","first-page":"E2297","DOI":"10.1210\/jc.2012-1923","volume":"97","author":"PS Walsh","year":"2012","unstructured":"Walsh PS, Wilde JI, Tom EY, Reynolds JD, Chen DC, Chudova DI, et al. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. J Clin Endocrinol Metab. 2012;97(12):E2297\u2013306.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"693_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/0003-4819-159-5-201309030-00006","volume":"159","author":"ES Cibas","year":"2013","unstructured":"Cibas ES, Baloch ZW, Fellegara G, LiVolsi VA, Raab SS, Rosai J, et al. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013;159(5):325\u201332.","journal-title":"Ann Intern Med"},{"issue":"7","key":"693_CR30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1089\/thy.2015.0049","volume":"25","author":"E Brauner","year":"2015","unstructured":"Brauner E, Holmes BJ, Krane JF, Nishino M, Zurakowski D, Hennessey JV, et al. Performance of the Afirma gene expression classifier in Hurthle cell thyroid nodules differs from other indeterminate thyroid nodules. Thyroid. 2015;25(7):789\u201396.","journal-title":"Thyroid"},{"issue":"10","key":"693_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cncy.21455","volume":"122","author":"RR Lastra","year":"2014","unstructured":"Lastra RR, Pramick MR, Crammer CJ, LiVolsi VA, Baloch ZW. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience. Cancer Cytopathol. 2014;122(10):737\u201344.","journal-title":"Cancer Cytopathol."},{"key":"693_CR32","doi-asserted-by":"publisher","unstructured":"Harrell RM, Bimston DN. Surgical utility of Afirma: effects of high Cancer prevalence and Oncocytic cell types in patients with indeterminate thyroid cytology. Endocr Pract. 2013. \n                    https:\/\/doi.org\/10.4158\/EP13330.OR:1-16\n                    \n                  .","DOI":"10.4158\/EP13330.OR:1-16"},{"issue":"7","key":"693_CR33","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1089\/thy.2015.0505","volume":"26","author":"JX Wu","year":"2016","unstructured":"Wu JX, Young S, Hung ML, Li N, Yang SE, Cheung DS, et al. Clinical factors influencing the performance of gene expression classifier testing in indeterminate thyroid nodules. Thyroid. 2016;26(7):916\u201322.","journal-title":"Thyroid"},{"issue":"9","key":"693_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","volume":"153","author":"KN Patel","year":"2018","unstructured":"Patel KN, Angell TE, Babiarz J, Barth NM, Blevins T, Duh QY, et al. Performance of a genomic sequencing classifier for the preoperative diagnosis of Cytologically indeterminate thyroid nodules. JAMA Surg. 2018;153(9):817\u201324.","journal-title":"JAMA Surg"},{"issue":"1","key":"693_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"key":"693_CR36","unstructured":"Kuhn M, contributions from Wing J, Weston S, Williams A, Keefer C, Engelhardt A, et al. caret: Classification and Regression Training. R package version 6.0\u201368. 2016. \n                    https:\/\/CRAN.R-project.org\/package=caret\n                    \n                  . Accessed 5 Aug 2018."},{"issue":"6","key":"693_CR37","first-page":"1954","volume":"5","author":"I Kurelac","year":"2015","unstructured":"Kurelac I, de Biase D, Calabrese C, Ceccarelli C, Ng CK, Lim R, et al. High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants. Am J Cancer Res. 2015;5(6):1954\u201371.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"693_CR38","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1210\/jc.2002-020339","volume":"87","author":"N Wada","year":"2002","unstructured":"Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH. Chromosomal aberrations by comparative genomic hybridization in hurthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab. 2002;87(10):4595\u2013601.","journal-title":"J Clin Endocrinol Metab"},{"key":"693_CR39","doi-asserted-by":"publisher","unstructured":"Harrell RM, Eyerly-Webb SA, Golding AC, Edwards CM, Bimston DN. Statistical Comparison of Afirma GSC and Afirma GEC Outcomes in a Community Endocrine Surgical Practice: Early Findings. Endocr Pract. 2018. \n                    https:\/\/doi.org\/10.4158\/EP-2018-0395\n                    \n                  .","DOI":"10.4158\/EP-2018-0395"},{"issue":"Supp 1","key":"693_CR40","first-page":"A-189","volume":"28","author":"E Marqusee","year":"2018","unstructured":"Marqusee E, Heller HT, Cibas ES, Barletta JA, Kim MI, Krane JF, et al. An independent performance comparison of the Afirma genomic sequencing classifier (GSC) and gene expression classifier (GEC) for cytologically indeterminate thyroid nodules. Thyroid. 2018;28(Supp 1):A-189.","journal-title":"Thyroid"},{"issue":"Supp 1","key":"693_CR41","first-page":"A-196","volume":"28","author":"CE Nasr","year":"2018","unstructured":"Nasr CE, Krishnamurthy VD. Automatic identification of Hurthle cells and Hurthle neoplasia by two classifiers that coordinate with the core Afirma GSC classifier. Thyroid. 2018;28(Supp 1):A-196.","journal-title":"Thyroid"},{"issue":"4","key":"693_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1089\/thy.2015.0508","volume":"26","author":"HK Su","year":"2016","unstructured":"Su HK, Wenig BM, Haser GC, Rowe ME, Asa SL, Baloch Z, et al. Inter-observer variation in the pathologic identification of minimal Extrathyroidal extension in papillary thyroid Carcinoma. Thyroid. 2016;26(4):512\u20137.","journal-title":"Thyroid"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-019-0693-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-019-0693-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-019-0693-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T23:13:54Z","timestamp":1585955634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-019-0693-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":42,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1186\/s12918-019-0693-z","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"5 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained prior to the initiation of the studies described in this manuscript. Study samples were collected according to protocols that were reviewed and approved by study site institutional review boards (IRB) or central IRBs (Liberty IRB, DeLand, Florida; now Chesapeake IRB, and Copernicus Group Independent Review Board, Cary, North Carolina).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YH, RTK, JB, SYK, GF, PSW, JH, and GCK are employed by Veracyte, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"27"}}